نتایج جستجو برای: pah

تعداد نتایج: 7545  

Journal: :Circulation 2016
Steven Hsu Brian A Houston Emmanouil Tampakakis Anita C Bacher Parker S Rhodes Stephen C Mathai Rachel L Damico Todd M Kolb Laura K Hummers Ami A Shah Zsuzsanna McMahan Celia P Corona-Villalobos Stefan L Zimmerman Fredrick M Wigley Paul M Hassoun David A Kass Ryan J Tedford

BACKGROUND Right ventricular (RV) functional reserve affects functional capacity and prognosis in patients with pulmonary arterial hypertension (PAH). PAH associated with systemic sclerosis (SSc-PAH) has a substantially worse prognosis than idiopathic PAH (IPAH), even though many measures of resting RV function and pulmonary vascular load are similar. We therefore tested the hypothesis that RV ...

2016
Sébastien Sanges Cécile M. Yelnik Olivier Sitbon Olivier Benveniste Kuberaka Mariampillai Mathilde Phillips-Houlbracq Christophe Pison Christophe Deligny Jocelyn Inamo Vincent Cottin Luc Mouthon David Launay Marc Lambert Pierre-Yves Hatron Laurence Rottat Marc Humbert Eric Hachulla

Occurrence of pulmonary arterial hypertension (PAH) in idiopathic inflammatory myopathies (IIMs) without extensive interstitial lung disease (ILD) has rarely been described in the medical literature. This study aimed to report all cases with association of PAH and IIM in the French Pulmonary Hypertension (PH) Registry, to identify IIM features associated with the presence of PAH, and to describ...

2017
Heon-Woo Lee Suk-Won Jin

Pulmonary artery hypertension (PAH) is a rare lung disorder in which the arteries that carry blood from the heart to the lungs progressively narrow down, making it difficult for blood to flow through the vessels. In many cases, PAH leads to right ventricular failure. The recent estimate of 1-, 3-, and 5-year survival rates from the time of diagnosis were estimated to be 87.7%, 72.1% , and 60.3%...

Journal: :European heart journal 2014
Alessandra Manes Massimiliano Palazzini Enri Leci Maria L Bacchi Reggiani Angelo Branzi Nazzareno Galiè

AIMS This study compared the clinical, functional, and haemodynamic characteristics and current era survival of subgroups of patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD): Eisenmenger syndrome (ES); PAH-CHD associated with systemic-to-pulmonary shunts (SPs); PAH with small defects (SDs); and PAH after defect correction (CDs). METHODS AND RESU...

Journal: :Circulation 2013
Silvia Rain M Louis Handoko Pia Trip C Tji-Joong Gan Nico Westerhof Ger J Stienen Walter J Paulus Coen A C Ottenheijm J Tim Marcus Peter Dorfmüller Christophe Guignabert Marc Humbert Peter Macdonald Cris Dos Remedios Piet E Postmus Chandra Saripalli Carlos G Hidalgo Henk L Granzier Anton Vonk-Noordegraaf Jolanda van der Velden Frances S de Man

BACKGROUND The role of right ventricular (RV) diastolic stiffness in pulmonary arterial hypertension (PAH) is not well established. Therefore, we investigated the presence and possible underlying mechanisms of RV diastolic stiffness in PAH patients. METHODS AND RESULTS Single-beat RV pressure-volume analyses were performed in 21 PAH patients and 7 control subjects to study RV diastolic stiffn...

Journal: :Molecular and biochemical parasitology 2011
Lon-Fye Lye Song Ok Kang Joshua D Nosanchuk Arturo Casadevall Stephen M Beverley

Aromatic amino acid hydroxylases (AAAH) typically use tetrahydrobiopterin (H(4)B) as the cofactor. The protozoan parasite Leishmania major requires biopterin for growth and expresses strong salvage and regeneration systems to maintain H(4)B levels. Here we explored the consequences of genetic manipulation of the sole L. major phenylalanine hydroxylase (PAH) to explore whether it could account f...

Journal: :Current rheumatology reports 2007
Christopher P Denton Svetlana I Nihtyanova

Pulmonary arterial hypertension (PAH) affects 10% to 15% of patients with systemic sclerosis and is a major cause for disease-related morbidity and mortality. Over the past decade, significant progress has been made in the understanding of the pathophysiologic mechanisms underlying PAH. This progress led to the development of several new treatment options and, as a result, dramatically improved...

2017
Alexandra C. van Dissel Barbara J. M. Mulder Berto J. Bouma

Pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD) is a common type of pulmonary arterial hypertension (PAH) and a frequent complication of congenital heart disease (CHD). PAH-CHD represents a heterogeneous patient population and it is important to distinguish between the underlying cardiac defects considering the prognostic and therapeutic implications. Improved...

Journal: :Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2011
E M Leter A B Boonstra F B Postma J J P Gille E J Meijers-Heijboer A Vonk Noordegraaf

We report three cases which highlight the complex considerations surrounding genetic counselling for pulmonary arterial hypertension (PAH). The first counselee developed PAH symptoms shortly after his daughter's death from PAH and was diagnosed with a delay of 1 year. An early diagnosis of familial PAH was established in the second counselee. Oral therapy was initiated immediately, and her func...

2015
Robin Condliffe Luke S. Howard

Although rare in its idiopathic form, pulmonary arterial hypertension (PAH) is not uncommon in association with various associated medical conditions, most notably connective tissue disease (CTD). In particular, it develops in approximately 10% of patients with systemic sclerosis and so these patients are increasingly screened to enable early detection. The response of patients with systemic sc...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید